Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
or

Metagenomi Inc (MGX)

Metagenomi Inc (MGX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.3200 -0.0400 (-2.94%) 04/01/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 1.3300 +0.0100 (+0.76%) 19:50 ET
Quote Overview for Tue, Apr 1st, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2901
Day High
1.3700
Open 1.3700
Previous Close 1.3600 1.3600
Volume 523,400 523,400
Avg Vol 406,410 406,410
Stochastic %K 2.93% 2.93%
Weighted Alpha -89.43 -89.43
5-Day Change -0.2700 (-16.98%) -0.2700 (-16.98%)
52-Week Range 1.2901 - 10.9350 1.2901 - 10.9350
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 50,841
  • Shares Outstanding, K 37,383
  • Annual Sales, $ 52,300 K
  • Annual Income, $ -78,060 K
  • EBIT $ -89 M
  • EBITDA $ -91 M
  • 60-Month Beta N/A
  • Price/Sales 1.06
  • Price/Cash Flow N/A
  • Price/Book 0.24

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.65
  • Number of Estimates 3
  • High Estimate -0.52
  • Low Estimate -0.87
  • Prior Year -1.19
  • Growth Rate Est. (year over year) +45.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2901 +2.32%
on 04/01/25
Period Open: 2.0500
2.0950 -36.99%
on 03/10/25
-0.7300 (-35.61%)
since 02/28/25
3-Month
1.2901 +2.32%
on 04/01/25
Period Open: 3.6100
4.0550 -67.45%
on 01/02/25
-2.2900 (-63.43%)
since 12/31/24
52-Week
1.2901 +2.32%
on 04/01/25
Period Open: 10.8200
10.9350 -87.93%
on 04/04/24
-9.5000 (-87.80%)
since 04/01/24

Most Recent Stories

More News
Metagenomi Reports Business Updates and Full Year 2024 Financial Results

MGX : 1.3200 (-2.94%)
Mineralys, Tenaya, SpringWorks, COSCIENS, Metagenomi: 5 Biotech Stocks That Led Retail Follower Growth Last Week

Positive data from clinical trials, earnings readouts, M&A speculation and new research drew heavy interest from retail traders on Stocktwits for these tickers for the week ended March 14, 2025.

TNYA : 0.5440 (-4.58%)
CSCI : 2.87 (+1.77%)
MLYS : 13.84 (-12.85%)
SWTX : 41.88 (-5.10%)
MGX : 1.3200 (-2.94%)
Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

MGX : 1.3200 (-2.94%)
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference

MGX : 1.3200 (-2.94%)
Stargate, Netflix, GE Aerospace, Twilio, and More

There's a lot for investors to talk about.

NFLX : 928.38 (-0.45%)
META : 586.00 (+1.67%)
GOOGL : 157.07 (+1.57%)
NVDA : 110.15 (+1.63%)
GOOG : 158.88 (+1.70%)
TWLO : 98.17 (+0.27%)
ATEN : 16.62 (+1.71%)
F : 9.94 (-0.90%)
JPM : 243.66 (-0.67%)
RKLB : 18.15 (+1.51%)
NKE : 64.76 (+2.02%)
ORCL : 141.94 (+1.52%)
Metagenomi Highlights Progress Across Therapeutic Portfolio and Outlines Anticipated Milestones

MGX : 1.3200 (-2.94%)
Metagenomi Announces New Appointment to its Board of Directors

MGX : 1.3200 (-2.94%)
Metagenomi to Present at the 43rd Annual J.P. Morgan Healthcare Conference

MGX : 1.3200 (-2.94%)
2 ‘Monster’ Stocks to Snap Up Before 2025

Analysts at Jefferies have identified Metagenomi and Structure Therapeutics as two "monster" stocks in the biotech sector, with potential gains of up to 1,000%.

GPCR : 15.79 (-8.78%)
MGX : 1.3200 (-2.94%)
Metagenomi Presents Highly Specific and Efficient Genome Editing Tools at Nature Conference “RNA at the Bench and Bedside IV”

MGX : 1.3200 (-2.94%)

Business Summary

Metagenomi Inc. is a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived gene editing toolbox. Metagenomi Inc. is based in EMERYVILLE, Calif.

See More

Key Turning Points

3rd Resistance Point 1.4432
2nd Resistance Point 1.4066
1st Resistance Point 1.3633
Last Price 1.3200
1st Support Level 1.2834
2nd Support Level 1.2468
3rd Support Level 1.2035

See More

52-Week High 10.9350
Fibonacci 61.8% 7.2506
Fibonacci 50% 6.1126
Fibonacci 38.2% 4.9745
Last Price 1.3200
52-Week Low 1.2901

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trading Volatility: How to Use IV Rank & Percentile for Smarter Options Strategies